Molecular Whole-Body Cancer Staging Using Positron Emission Tomography: Consequences for Therapeutic Management and Metabolic Radiation Treatment Planning

Authors :: Richard P. Baum
Christian Przetak
Norbert Presselt
Eric Lopatta
Michael Schmücking
Thomas G. Wendt
Frank Griesinger
Bernhard Herse
R. Bonnet
Jochen Leonhardi
Andreas Niesen
Source :: Molecular Staging of Cancer ISBN: 9783642639456
Publication Year :: 2003
Publisher :: Springer Berlin Heidelberg, 2003.
Abstract: A prospective analysis was performed in 124 non-small cell lung cancer patients to determine the role of F-18 fluorodeoxyglucose (FDG)-positron emission tomography (PET) for molecular (metabolic) staging (n=63), therapy monitoring after induction-chemotherapy (n=34), and conformai radiation treatment planning (n=27). Staging by FDG-PET was significantly more accurate than CT (p

Subjects :: Fluorodeoxyglucose
medicine.medical_specialty
medicine.diagnostic_test
business.industry
medicine.medical_treatment
medicine.disease
Radiation therapy
medicine.anatomical_structure
Positron emission tomography
medicine
Radiology
business
Radiation treatment planning
Nuclear medicine
Prospective cohort study
Lymph node
Progressive disease
medicine.drug
Cancer staging

Full Text Access

Tools